enrasentan has been researched along with tezosentan in 3 studies
Studies (enrasentan) | Trials (enrasentan) | Recent Studies (post-2010) (enrasentan) | Studies (tezosentan) | Trials (tezosentan) | Recent Studies (post-2010) (tezosentan) |
---|---|---|---|---|---|
32 | 2 | 0 | 157 | 29 | 33 |
Protein | Taxonomy | enrasentan (IC50) | tezosentan (IC50) |
---|---|---|---|
Endothelin receptor type B | Homo sapiens (human) | 0.021 | |
Endothelin-1 receptor | Homo sapiens (human) | 0.0205 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Clark, A; Cleland, JG; Crabbe, S; Ford, S; Houghton, T; Louis, A; Thackray, S | 1 |
Boerrigter, G; Burnett, JC | 1 |
Minushkina, LO; Sidorenko, BA; ZateÄshchikov, DA | 1 |
3 review(s) available for enrasentan and tezosentan
Article | Year |
---|---|
Clinical Trials Update: CAPRICORN, COPERNICUS, MIRACLE, STAF, RITZ-2, RECOVER and RENAISSANCE and cachexia and cholesterol in heart failure. Highlights of the Scientific Sessions of the American College of Cardiology, 2001.
Topics: Adrenergic beta-Antagonists; Atrial Fibrillation; Cachexia; Carbazoles; Carboxylic Acids; Carvedilol; Cholesterol; Cytokines; Endothelins; Heart Failure; Humans; Indans; Injections, Intravenous; Myocardial Infarction; Propanolamines; Pyridines; Tetrazoles; United States; Vasodilator Agents | 2001 |
Endothelin in neurohormonal activation in heart failure.
Topics: Animals; Carboxylic Acids; Endothelin Receptor Antagonists; Endothelins; Endothelium, Vascular; Heart; Heart Failure; Humans; Indans; Neurotransmitter Agents; Pyridines; Tetrazoles; Vasodilator Agents | 2003 |
[Endothelin receptor blockers--one more agent for the treatment of pulmonary hypertension].
Topics: Antihypertensive Agents; Bosentan; Carboxylic Acids; Clinical Trials as Topic; Endothelin Receptor Antagonists; Endothelium, Vascular; Humans; Hypertension, Pulmonary; Indans; Pyridines; Sulfonamides; Tetrazoles; Vasodilator Agents | 2003 |
1 trial(s) available for enrasentan and tezosentan
Article | Year |
---|---|
Clinical Trials Update: CAPRICORN, COPERNICUS, MIRACLE, STAF, RITZ-2, RECOVER and RENAISSANCE and cachexia and cholesterol in heart failure. Highlights of the Scientific Sessions of the American College of Cardiology, 2001.
Topics: Adrenergic beta-Antagonists; Atrial Fibrillation; Cachexia; Carbazoles; Carboxylic Acids; Carvedilol; Cholesterol; Cytokines; Endothelins; Heart Failure; Humans; Indans; Injections, Intravenous; Myocardial Infarction; Propanolamines; Pyridines; Tetrazoles; United States; Vasodilator Agents | 2001 |